Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow

Ítems similars

• Pre- and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia
  per: Zhou, Yi, et al.
  Publicat: (2016)
• Cyclosporine Modulation of Multidrug Resistance in Combination with Pravastatin, Mitoxantrone, and Etoposide for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML): A Phase 1/2 Study
  per: Chen, Tara L., et al.
  Publicat: (2013)
• Effect of Measurable (“Minimal”) Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia
  per: Othus, Megan, et al.
  Publicat: (2016)
• Impact of Residual Normal Metaphases in Core Binding Factor Acute Myeloid Leukemia
  per: Medeiros, Bruno C., et al.
  Publicat: (2011)
• Impact of lymphocyte count at diagnosis on acute myeloid leukemia outcome
  per: Bar, Merav, et al.
  Publicat: (2015)